ZEISS Medical Technology has received FDA 510(k) clearance for MTLawton\u2122, the new disposable bipolar forceps made from a special copper-base alloy that potentially reduces tissue adhesion and subsequent charring during dissection of tissue. Thanks to the extended shaft, the forceps also reduce visual restrictions in the surgical field and help surgeons to be efficient during electrosurgical procedures.<\/p>\n\n\n\n
The development of the new bipolar forceps from ZEISS is based on close collaboration with Michael T. Lawton, one of the world’s leading neurosurgeons. <\/p>\n\n\n\n
“The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps. Our copper-base alloy has superior thermal conduction to improve cautery-based hemostasis and reduce tissue adhesion,” emphasizes Michael T. Lawton, MD, President and CEO, Chair, Department of Neurosurgery, Barrow Neurological Institute, Phoenix\/Arizona (USA). “I take these MTLawton bipolars into battle with all my difficult arteriovenous malformations, and they give me a noticeable advantage.”<\/p>\n\n\n\n
MTLawton takes non-stick technology to a new level by introducing Zeiss’ bipolar forceps made of a special copper-base alloy. The improved material conducts heat away from the silver-plated tips faster to potentially reduce tissue adhesion and charring .<\/p>\n\n\n\n
MTLawton has an elegant shape and extended working length that allows a clear view of the cauterization area even in narrow and deep cavities. With the copper-based material, MTLawton is also robust and enables surgeons to handle tissue more efficiently.<\/p>\n\n\n\n
ZEISS acquired Kogent Surgical in April 2022 and has expanded its range of surgical solutions for microsurgery. MTLawton is the first surgical instrument from this acquisition to the market with FDA approval for MTLawton, according to Dr. Markus Weber, CEO of Carl Zeiss Meditec<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" The surgical instrument reduces tissue adhesion and allows a clear view of the coagulation for efficient preparation<\/p>\n","protected":false},"author":2,"featured_media":14559,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,25,677],"tags":[687,854],"class_list":["post-14558","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-products-technologies","category-surgical","tag-fda","tag-zeiss"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/14558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=14558"}],"version-history":[{"count":6,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/14558\/revisions"}],"predecessor-version":[{"id":14568,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/14558\/revisions\/14568"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/14559"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=14558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=14558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=14558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}